Peng, L., Wang, Q., Wang, C., Lan, M., He, W., Wu, L., Wan, G., Han, Y. (2025). Sequential chemo-immunotherapy as a novel bridging strategy for non-complete responders after neoadjuvant chemoradiotherapy in esophageal cancer: First prospective phase 2 trial challenging the immediate-surgery paradigm.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4066